Edgewell Personal Care (EPC) Research & Development (2009 - 2026)

Edgewell Personal Care (EPC) has reported Research & Development for 18 consecutive years, with $13.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development fell 1.48% year-over-year to $13.3 million in Q2 2026; TTM through Jun 2026 was $59.4 million, a 4.95% increase from a year earlier, with the FY2025 full-year figure at $57.6 million, down 1.37% from the prior year.
• Research & Development was $13.3 million for Q2 2026 at Edgewell Personal Care, down from $14.9 million in the prior quarter.
• Over five years, Research & Development peaked at $17.4 million in Q3 2025 and troughed at $13.3 million in Q4 2023.
• A 5-year average of $14.4 million and a median of $14.0 million in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development slipped 7.53% in 2025 and gained 11.19% in 2026, its largest moves.
• Over 5 years, Research & Development stood at $13.4 million in 2022, then fell by 0.75% to $13.3 million in 2023, then rose by 0.75% to $13.4 million in 2024, then climbed by 2.99% to $13.8 million in 2025, then slipped by 3.62% to $13.3 million in 2026.
• The last three Research & Development figures came in at $13.3 million (Q2 2026), $14.9 million (Q1 2026), and $13.8 million (Q4 2025), per Business Quant data.